SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
NorthStrive completed a private placement of 231,750 units to the Sponsor at $10.00 per unit, generating $2,317,500 in gross proceeds, pursuant to Section 4(a)(2) exemption from registration, simultaneously with the IPO closing.
View raw filing on EDGAR →The filing discloses entry into a First Amended and Restated Purchase Agreement granting an investor the right to purchase up to $75 million of unregistered common stock shares at discounted prices (95% or 75% of market price depending on trading status), increased from $25 million under the original agreement. This is a classic equity line of credit (ELOC) arrangement—an unregistered private placement of equity securities with dilutive pricing mechanics. Item 3.02 explicitly incorporates the securities description, confirming this as an unregistered equity issuance event.
View raw filing on EDGAR →The filing discloses a firm commitment underwritten public offering of 3,437,500 shares of common stock at $3.20 per share, generating $11 million in gross proceeds. This is a registered equity issuance under an effective Form S-3 shelf registration statement, representing a material capital raise that dilutes existing shareholders. The press release explicitly states the offering is expected to close on August 21, 2026, and details the use of proceeds for R&D, sales and marketing, and working capital.
View raw filing on EDGAR →The filing discloses conversion of $3,000,000 in debt into 1,829,268 shares of common stock at $1.64 per share, executed via a Debt Conversion Agreement with Rare Earth Financial, LLC. This is a dilutive equity issuance that increases share count materially. While Item 1.01 frames it as a material definitive agreement and Item 3.02 explicitly addresses unregistered equity sales, the core event is the issuance of equity securities in exchange for debt cancellation, which is a classic dilutive capital transaction.
View raw filing on EDGAR →This press release announces the completion of a US$4.0 million private placement of 4.0 million ordinary shares at US$1.00 per share—an unregistered equity issuance by a small-cap public company. The transaction is a classic dilutive equity raise: common shares issued in a private placement exempt from Securities Act registration, with no warrants or convertibles. The 160% premium to the prior closing price and the capital infusion are material to investors assessing the company's financial position and ownership structure.
View raw filing on EDGAR →Newton Golf Company entered into a Securities Purchase Agreement on August 14, 2026 for a private placement of common stock with up to $5,000,000 in aggregate proceeds (first tranche of $1,000,000 closed immediately). The shares are unregistered securities sold pursuant to Section 4(a)(2) and Regulation D exemptions to accredited investors. This is a classic dilutive equity issuance disclosed under Item 1.01 and Item 3.02, representing a material capital raise that dilutes existing shareholders.
View raw filing on EDGAR →The filing discloses adjustment of warrant exercise prices and share counts following a 45-for-1 share consolidation effected in August 2026. The warrant adjustments—reducing exercise price to $3.80 per share and increasing shares issuable to approximately 3,193,862—reflect anti-dilution provisions triggered by the consolidation and prior offerings in May, July, and August 2026. While the primary event is a technical warrant adjustment rather than a new issuance, the disclosure concerns dilutive equity instruments (warrants) and their adjustment mechanics, which materially affect shareholder dilution and capital structure.
View raw filing on EDGAR →Rise Companies Corp. qualified 4,275,000 shares of Class B Common Stock for sale in a continuous offering under Regulation A (Rule 251(d)(3)), with an expected offering period through September 23, 2028. This unregistered equity issuance will dilute existing shareholders and raise capital for the company.
View raw filing on EDGAR →The filing discloses unregistered sales of equity securities totaling approximately $33.9 million across two share classes (Class C and Class L) sold on July 1 and August 1, 2026. The sales were exempt from registration under Section 4(a)(2), Regulation S, and Regulation D—classic private placement mechanics. This represents a material dilutive issuance that would affect investor assessment of ownership and capital structure.
View raw filing on EDGAR →On August 19, 2026, Sadot Group Inc. issued 33,968 common shares at a below-market price to settle an assigned debenture with an existing debt holder, relying on the Section 3(a)(9) exemption. The debt-for-equity conversion resulted in dilution to existing shareholders and triggered anti-dilution adjustments in other debt instruments.
View raw filing on EDGAR →WF International entered into a Share Purchase Agreement on August 19, 2026, to sell and issue 111,333 ordinary shares at $1.50 per share in a registered direct offering, expected to close August 21, 2026. The offering is registered under Form F-3 and will raise approximately $166,999.50 in gross proceeds. This is a registered direct offering of equity securities that dilutes existing shareholders and is material to investor assessment of capital structure and ownership.
View raw filing on EDGAR →Monroe Capital issued 1,664,638 shares of common stock at $9.77 per share for an aggregate offering price of $16.3 million pursuant to subscription agreements, exempt from registration under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →In connection with the exchangeable notes offering, Dynatrace's subsidiary issued warrants to purchase up to 44.7 million shares of common stock, and up to 30.2 million shares of common stock are potentially issuable upon exchange of the notes. The warrant and exchange transactions were issued in a private placement under Rule 144A and Section 4(a)(2), creating potential dilution to existing shareholders.
View raw filing on EDGAR →Blackstone Private Credit Fund completed an unregistered private placement of 1,339,715 Class I common shares for $31.7 million, conducted pursuant to Section 4(a)(2) and Regulation S exemptions.
View raw filing on EDGAR →Nexalin entered into a securities purchase agreement on August 19, 2026, to issue 2,419,355 shares of common stock at $0.31 per share and common warrants to purchase 1,209,677 additional shares at $0.50 per share in a registered direct offering raising approximately $750,000, plus an any-market purchase agreement (AMPA) for up to $15 million in future share purchases. The company also issued unregistered equity securities including Common Warrants, Pre-Funded Warrants (with $0.001 exercise price), and AMPA Shares to accredited investors pursuant to Regulation D, materially increasing share count and dilution to existing shareholders.
View raw filing on EDGAR →Barings Private Credit Corp completed an unregistered sale of approximately 5.1 million shares of common stock for $101.5 million pursuant to Section 4(a)(2) and Regulation D/S. This private placement materially increases share count and dilutes existing shareholders' ownership percentages and earnings per share.
View raw filing on EDGAR →North Haven Net REIT sold an aggregate of 289,618 Class I shares and 5,591 Class F-I shares for approximately $6.15 million in total consideration to a feeder vehicle. The sale was structured as an unregistered offering under Section 4(a)(2) and Regulation D Rule 506, which is the classic structure for dilutive equity issuances. The materiality threshold is clearly met given the substantial dollar amount and share count involved.
View raw filing on EDGAR →ZeroStack issued 3.5 million common shares and pre-funded warrants to purchase 36.2 million additional shares in a private placement to Puple AI Inc. and Blockcat Pte. Ltd. in exchange for $1 billion in MemeCore tokens, representing substantial dilution to existing shareholders and relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →EDAP TMS disclosed the closing of an underwritten public offering of 8,425,000 ADSs at $4.75 per share on August 14, 2026, plus the full exercise of a 30-day greenshoe option for an additional 1,263,750 ADSs expected to close on August 19, 2026, generating approximately $5.6 million in net proceeds. This is a material dilutive equity issuance that increases the share count and raises capital, fitting the dilutive_issuance category.
View raw filing on EDGAR →Datavault AI issued 15,000,000 pre-delivery shares and a $25,030,000 convertible promissory note to Streeterville Capital in a private placement, with conversion rights at $1.55 per share and a reinvestment option for up to an additional $25,000,000. The transaction includes a 300,000,000-share reserve for conversion shares and requires Nasdaq stockholder approval, representing substantial dilution to existing shareholders.
View raw filing on EDGAR →XCel Brands entered into an Equity Distribution Agreement with Maxim Group LLC authorizing the sale of up to $10,000,000 of common stock through an at-the-market (ATM) offering on the Nasdaq Capital Market. This is a registered direct offering of equity securities that will dilute existing shareholders and is material to investors assessing the company's capital structure and financing strategy.
View raw filing on EDGAR →The filing discloses registration of resale shares pursuant to a Stock Purchase Agreement dated February 11, 2026 between Twist Bioscience and Invenra, with a Registration Rights Agreement governing the resale. This represents a dilutive equity issuance to a third party (Invenra) with contractual resale rights, which is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →Opendoor issued convertible notes with a maximum of 186.2 million shares of common stock issuable upon conversion at a rate of 286.5329 shares per $1,000 principal, representing a material dilutive issuance of equity securities under the Section 3(a)(9) exemption.
View raw filing on EDGAR →The 6-K discloses unregistered sales of 847,591 Class A ordinary shares (in three separate tranches on August 4, 2026) issued for consulting and renovation services at an aggregate value of approximately US$600,000 plus SGD 300,000. These shares were issued pursuant to Section 4(a)(2) exemption and represent dilutive equity issuances to unaffiliated third parties. The disclosure explicitly states the shares "have not been and will not be registered under the Securities Act," confirming this is an unregistered private placement—a classic dilutive issuance event material to investors assessing ownership and capital structure.
View raw filing on EDGAR →The filing discloses the completion of an initial public offering (IPO) and the full exercise of the over-allotment option, resulting in the issuance of 7,187,500 shares of common stock and gross proceeds of approximately $93.4 million. While technically an IPO is a registered offering (not an unregistered private placement), the core event—creation of a substantial new direct financial obligation through equity issuance—aligns with the dilutive_issuance category. This is material to investors as it represents a significant capital raise and equity dilution event.
View raw filing on EDGAR →Marvell issued a warrant to Google for up to 58,970,907 shares of common stock at $206.58 per share in connection with a commercial agreement for custom semiconductor products. The warrant vests over time based on time-based tranches and discretionary purchases through fiscal 2033, creating significant dilution potential. This unregistered equity issuance under Section 4(a)(2) exemption represents a material dilutive event affecting shareholder ownership and capital structure.
View raw filing on EDGAR →The 6-K announces the closing of an initial public offering of 4,285,714 ADSs representing 21,438,570 ordinary shares on August 19, 2026. While technically an IPO is a registered offering (not an unregistered private placement), it represents a material dilutive issuance of equity that creates a new class of public shareholders and fundamentally alters the company's capital structure. This is a material event affecting investor assessment of ownership and control.
View raw filing on EDGAR →Stepstone Private Credit Fund LLC completed an unregistered sale of 1,134,111 LLC interests for $29.5 million pursuant to subscription agreements under Section 4(a)(2), Regulation D, and Regulation S exemptions.
View raw filing on EDGAR →Apollo Debt Solutions BDC sold 337,710 unregistered Class I Common Shares for $8,047,437 to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This unregistered equity issuance represents a significant capital raise and dilutes existing shareholders.
View raw filing on EDGAR →FrontView REIT entered into an Amended and Restated Distribution Agreement authorizing the sale of up to $125.0 million in common stock through an at-the-market (ATM) offering program with multiple sales agents and forward purchasers. With $50.7 million already sold and $74.3 million remaining available, this represents a substantial dilutive equity issuance mechanism. The inclusion of forward sale agreements (both contingent and non-contingent) further amplifies the dilutive potential. This is a classic ATM offering disclosure under Item 1.01, material to equity investors due to the significant authorized dilution.
View raw filing on EDGAR →TuHURA Biosciences issued 1,878,287 unregistered shares of common stock to Parkview Holdings as a fee for a $50 million revolving credit facility, relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →The 6-K discloses the closing of a private placement offering on August 17, 2026, in which Zeta Network Group issued 3,412,970 Class A ordinary shares and 3,412,970 warrants to investors for aggregate gross proceeds of US$10,000,002.10. The securities were unregistered and sold pursuant to Section 4(a)(2) and Regulation S exemptions, constituting a dilutive equity issuance material to investors assessing the company's capital structure and ownership.
View raw filing on EDGAR →HeartSciences issued 411,522 shares of common stock to Fortitude Mining Holdings in a private placement at $2.43 per share for approximately $1 million on August 12, 2026. This is a classic dilutive equity issuance in connection with a proposed business combination. The filing explicitly describes it as a "private placement" and notes that Fortitude now holds approximately 9.4% of HeartSciences' outstanding shares. While the transaction is also related to an ongoing M&A activity (the proposed merger with Fortitude), the primary disclosed event is the equity issuance itself, which is material to existing shareholders due to dilution.
View raw filing on EDGAR →The Company entered into a Securities Purchase Agreement on August 19, 2026, to sell $275,000 in principal amount of Debentures and conditional warrants in a private placement to accredited investors under Section 4(a)(2) and Regulation D exemptions. The Debentures automatically convert to Common Stock upon a future Public Offering, and the Warrants are exercisable for additional Common Stock, creating significant dilution contingent on future capital raising. This is a classic dilutive private placement raising cash through unregistered securities with conversion and warrant features that will dilute existing shareholders.
View raw filing on EDGAR →The filing discloses an at-the-market (ATM) offering agreement under which ASTC may sell up to $50 million of common stock through H.C. Wainwright & Co. as sales agent. The company has already sold 258,856 shares for $7.9 million under a prior prospectus supplement, and filed a new prospectus supplement on August 19, 2026 to increase the offering capacity to $50 million. This is a dilutive equity issuance that materially affects shareholder ownership and is a key capital-raising mechanism for small-cap companies.
View raw filing on EDGAR →The filing discloses Pre-Paid Purchase No. 5, a $100,000 investment by Streeterville Capital in an unsecured promissory note ($108,000 principal) that permits conversion into common stock at 90% of the lowest VWAP (floor $0.10/share), with a 9.99% beneficial ownership cap. Item 3.02 explicitly incorporates Item 1.01 and confirms unregistered sales under Section 4(a)(2) and Regulation D. This is a dilutive equity issuance mechanism, though the primary driver is also the company's financial distress (Floor Price trigger, mandatory repayments, workforce reduction of 20%).
View raw filing on EDGAR →The 6-K discloses a PIPE transaction (private investment in public equity) involving the issuance of 88,235 Class B ordinary shares at $3.40 per share for $300,000 in aggregate proceeds. The transaction closed on August 17, 2026, and the shares were issued in reliance on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This is a classic dilutive equity issuance by a small-cap foreign private issuer raising capital through unregistered securities, fitting the `dilutive_issuance` taxonomy precisely.
View raw filing on EDGAR →The Company issued 575,800 shares of common stock (103,800 + 172,000 + 300,000) in unregistered transactions to existing preferred stockholders in exchange for retirement of preferred shares. This is a classic dilutive issuance under Item 3.02, relying on Section 3(a)(9) exemption. The aggregate issuance is material in size and dilutes existing common shareholders without cash proceeds to the Company.
View raw filing on EDGAR →The Fund sold 627,661 Class I common shares for $16.7 million during August 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →NuRAN completed a private placement of 1,788,233 Series A convertible preferred shares for $7.6 million aggregate consideration, with $3 million in cash and the balance satisfied through settlement of convertible debt, accrued salary, and accounts payable. The issuance includes 200,000 A warrants and 1,588,233 B warrants, creating significant dilution to existing shareholders. This is a classic dilutive equity issuance by a small-cap company raising capital through unregistered securities, with related-party participation by the CEO, CFO, and CTO.
View raw filing on EDGAR →Blue Owl Real Estate Net Lease Trust sold 1,767,877 shares of Class I common shares to feeder vehicles for approximately $18.9 million in gross proceeds, with the offering exempt from registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →Ares Core Infrastructure Fund sold 32.3 million common shares for $799.5 million in aggregate consideration in an unregistered offering exempt under Section 4(a)(2) and Regulation D Rule 506(b), representing a material capital raise that dilutes existing shareholders.
View raw filing on EDGAR →Blue Owl Digital Infrastructure Trust sold 1,566,499 common shares for approximately $16.5 million in gross proceeds on August 3, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →The filing discloses an unregistered issuance of 3,500,000 Class A Ordinary Shares to the Sponsor upon conversion of Class B shares, relying on Section 3(a)(9) exemption. While technically a conversion rather than a new issuance, the Item 3.02 disclosure and the unregistered nature of the securities align with dilutive_issuance classification. The conversion increases Class A shares outstanding and materially affects the capital structure and voting dynamics of the SPAC.
View raw filing on EDGAR →This press release announces the closing of a private placement of 1,951,219 common shares (or pre-funded warrants) at CAD$2.84 per share, generating approximately CDN$5.54 million in gross proceeds. The offering also includes common share purchase warrants and placement agent warrants, creating dilution to existing shareholders. This is a classic unregistered equity issuance (private placement) that materially affects shareholder equity and voting power, fitting the dilutive_issuance category.
View raw filing on EDGAR →Alaska Silver closed a private investment in public equity (PIPE) financing on August 14, 2026, issuing 13,846,910 units (each comprising one common share and one warrant) at C$0.55 per unit for aggregate gross proceeds of C$7,615,800 to accredited investors under Regulation D Rule 506(b) and Canadian securities exemptions. The securities are unregistered and restricted under Rule 144 with a six-month hold period, and the company committed to file a resale registration statement within 120 days.
View raw filing on EDGAR →This exhibit is a PRC legal opinion issued in connection with YXT.COM GROUP HOLDING LIMITED's offering and sale of 500,000 American depositary shares (representing 15 million Class A ordinary shares) pursuant to a securities purchase agreement dated August 14, 2026. The opinion addresses the enforceability and validity of the transaction documents governing this unregistered equity issuance, which is a classic dilutive issuance event material to investors assessing ownership dilution and capital structure changes.
View raw filing on EDGAR →Existing shareholder KKR Genetic Disorder L.P. entered into an Underwriting Agreement for a secondary offering of 5,000,000 shares of common stock at $78.00 per share, with the Company not receiving proceeds but existing shareholders experiencing dilution of ownership percentages.
View raw filing on EDGAR →Slate Medicines conducted an oversubscribed concurrent private placement of $245 million in unregistered equity securities exempt under Section 4(a)(2) and Regulation D to healthcare investors, with proceeds to fund the combined company's operations into 2029.
View raw filing on EDGAR →The filing discloses entry into an Agency Agreement with Piper Sandler for marketing the Company's common stock in connection with a stock offering tied to a two-tier holding company reorganization. The offering is being conducted pursuant to a Form S-1 Registration Statement, indicating a public offering of equity securities. While the Item 1.01 caption references a "material definitive agreement," the substance is a dilutive equity issuance—the Company is raising capital through the sale of common stock to the public, which is material to existing shareholders.
View raw filing on EDGAR →